Proclaim
PrivateLast Round
VC Round
Feb 5, 2025
Total Funding Raised
$18M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Proclaim operates in Healthcare & Life Sciences and is based in Mountain View, California. Its latest recorded funding round was a VC Round in February 2025.
Proclaim is a healthtech company that provides a personalized and automated oral health system using 3D-printed, custom-fit mouthpieces.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, 3D Printing, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proclaim Comparables
Compare Proclaim with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Feno | 80% | |
| Helen of Troy Limited | 74% | |
| Autobrush | 68% |
For institutional investors. Book with your work email.
Proclaim Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 5, 2025 | ||||
| Series B | Jun 12, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Proclaim Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Asset Capital | VC Round, Series B |
| Khosla Ventures | Seed, Series B, VC Round |
| GEHA Ventures | VC Round |
| Revere Capital | Series B |
| SpringRock Ventures | Series B, VC Round |
| Ensemble Innovation Ventures | Series B, VC Round |
| Global Asset Capital | VC Round, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 31% MoM, reaching 3.2K.
- Jun 12, 2023
$15M round led by Khosla Ventures and Global Asset Capital.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 20, 2026
Fresh Health, Inc. launches the Proclaim Perio Pathway, powered by OralDNA(R) Labs, in California on Aug 20th '26 to identify disease-driving gum bacteria, manage them at home, and measure improvement through retesting; the pathway is available through more than 10,000 provider partners.
For institutional investors. Book with your work email.
Proclaim Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Proclaim's valuation, stock price, and market status.
Is Proclaim a public or private company?
Proclaim is a private company.
What is the current stock price of Proclaim?
Proclaim is a private company, so its shares have no public market price. Caplight tracks Proclaim's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Proclaim worth (valuation)?
Valuation information for Proclaim is not publicly available.
Can I buy Proclaim stock?
Proclaim shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Proclaim's last funding round?
Proclaim's most recent funding round was VC Round on February 5, 2025.
Who are the main investors in Proclaim?
Key investors in Proclaim include Global Asset Capital, Khosla Ventures, Global Asset Capital.
Will Proclaim IPO soon?
No public IPO plans have been announced for Proclaim.
How can I track Proclaim secondary market activity?
Caplight tracks bids, offers, and trades in Proclaim's shares on secondary markets.